HAVCR2 and Sepsis: Therefore, further investigation is required to determine whether the enhancement of the TIGIT pathway could confer a survival benefit in immunologically experienced hosts during sepsis, and how TIGIT coinhibitory signaling interacts with PD-1, 2B4, and TIM-3 on both effector and Tregs during sepsis.